A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,

Slides:



Advertisements
Similar presentations
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Meta-analysis of Functional Magnetic Resonance Imaging.
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: In Vivo Fibrillar β-Amyloid Detected Using [11C]PiB.
DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE  Kathryn A. Wyman-Chick, Phillip.
Fig. 1 The effects of modelling global volume for the analysis of PDD relative to controls. Atrophy in PDD shown (A) compensated for differences in head.
The C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation  Eino Solje, Päivi Hartikainen, Miko Valori, Ritva.
Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid.
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease  Azadeh Karami, Helga Eyjolfsdottir, Swetha.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Copyright © 2004 American Medical Association. All rights reserved.
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study Dement Geriatr Cogn Disord.
Dement Geriatr Cogn Disord Extra 2014;4: DOI: /
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints  Argonde C. van Harten, Pieter Jelle Visser,
KETOGENIC DIET EFFECTS ON BRAIN KETONE METABOLISM AND ALZHEIMER'S DISEASE CSF BIOMARKERS  Suzanne Craft, Bryan J. Neth, Akiva Mintz, Kiran Sai, Nora Shively,
Volume 247, Pages (January 2017)
The global prevalence of dementia: A systematic review and metaanalysis  Martin Prince, Renata Bryce, Emiliano Albanese, Anders Wimo, Wagner Ribeiro, Cleusa.
Small section of the neocortex from a patient with Alzheimer disease showing two classical neuropathologic lesions of the disease. A. The modified silver.
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment  Sanna-Kaisa Herukka,
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 2, Issue 1, Pages (January 2016)
The Neuropathology and Neurobiology of Traumatic Brain Injury
The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report  Carolin A.M. Koriath,
65 year-old female with Alzheimer’s disease
Alzheimer Disease Mayo Clinic Proceedings
The Neuropathology and Neurobiology of Traumatic Brain Injury
K. K. Noguchi, S. A. Johnson, G. A. Dissen, L. D. Martin, F. M
Marta Drake-Pérez, Enrique Marco de Lucas, John Lyo, José L
Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease  Jonathan Cedernaes, Ricardo S. Osorio, Andrew.
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
Probing the Biology of Alzheimer's Disease in Mice
Volume 15, Issue 13, Pages (December 2016)
When more means less Current Biology
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
A patient with early Alzheimer disease, 77 years of age, Mini-Mental State Examination score = 25. A patient with early Alzheimer disease, 77 years of.
Volume 77, Issue 2, Pages (January 2013)
Disruption of Large-Scale Brain Systems in Advanced Aging
Network hubs in the human brain
Tara L. Spires-Jones, Bradley T. Hyman  Neuron 
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Lisa Shah, MD  Journal of Pain and Symptom Management 
Biomarker Modeling of Alzheimer’s Disease
Figure 1 3D heat maps generated by GBM
Tharick A. Pascoal, Sulantha Mathotaarachchi, Monica Shin, Andrea L
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups.
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
In vivo tau imaging: Obstacles and progress
Neuroplasticity Failure in Alzheimer's Disease
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, Terry M
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Volume 24, Issue 1, Pages (July 2018)
Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology  Rebecca G. Smith,
Positron emission tomography study of regional cerebral blood flow and flow– metabolism coupling during general anaesthesia with xenon in humans†   S.
R.A. Armstrong, P.L. Lantos, N.J. Cairns  Pathophysiology 
[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β.
Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease  Antoine Leuzy, Elena Rodriguez-Vieitez,
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability.
Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease 
Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology?  Michael S. Unger,
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study  Osama Sabri, Marwan N. Sabbagh, John Seibyl, Henryk Barthel,
Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease  Alexander N.W. Taylor, Lana Kambeitz-Ilankovic, Benno.
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease  W. Robert Bell, Yang An,
Volume 120, Issue 2, Pages (February 2001)
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people  Oskar Hansson, Sebastian Palmqvist,
Suzanne E. Schindler, Julia D. Gray, Brian A
Figure 1 NMF in ADD patients and classification of prodromal Alzheimer’s disease participants. Grey matter ... Figure 1 NMF in ADD patients and classification.
Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology?  Michael S. Unger,
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER.
Presentation transcript:

A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively, C. Dirk Keene, Matthew J. Jorgensen, Rachel N. Andrews, Thomas C. Register, Thomas J. Montine, Angela M. Wilson, Bryan J. Neth, Akiva Mintz, Joseph A. Maldjian, Christopher T. Whitlow, Jay R. Kaplan, Suzanne Craft  Alzheimer's & Dementia: The Journal of the Alzheimer's Association  Volume 15, Issue 1, Pages 93-105 (January 2019) DOI: 10.1016/j.jalz.2018.06.3057 Copyright © 2018 The Authors Terms and Conditions

Fig. 1 (A), (B) Aβ plaques were histologically similar to those seen in human AD. (C) Focal vascular wall Aβ was also noted. (D), (E) granular cytoplasmic PHF-tau aggregates were present, but neurofibrillary tangles were rare. (F), (G) neuritic plaques were confirmed with Bielschowsky stain. Abbreviations: Aβ, β-amyloid; AD, Alzheimer's disease; PHF, paired helical filament. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2019 15, 93-105DOI: (10.1016/j.jalz.2018.06.3057) Copyright © 2018 The Authors Terms and Conditions

Fig. 2 The density of Aβ pathology is illustrated on a heat map. On average, Aβ plaque density is highest in the lateral temporal lobe and lowest in the medial temporal lobe regions. Aβ pathology was not identified in deep cerebral nuclei, brainstem, or cerebellum. Abbreviation: Aβ, β-amyloid. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2019 15, 93-105DOI: (10.1016/j.jalz.2018.06.3057) Copyright © 2018 The Authors Terms and Conditions

Fig. 3 The frequency with which AD neuropathologic change is identified in various brain regions is illustrated by increasing shades of gray such that the more frequently affected areas are darker. (A) Aβ plaques are distributed throughout the cerebral cortex and are most often found in the posterior middle temporal gyrus followed by the posterior cingulate gyrus. (B) PHF-tau immunoreactivity is distributed throughout the cortex and the deep gray nuclei, including caudate nucleus, putamen, and globus pallidus. Abbreviations: Aβ, β-amyloid; AD, Alzheimer's disease; PHF, paired helical filament. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2019 15, 93-105DOI: (10.1016/j.jalz.2018.06.3057) Copyright © 2018 The Authors Terms and Conditions

Fig. 4 (A) Guanidine-extracted Aβ42 (dark bars) and Aβ40 (striped bars) levels in temporal (T) and parietal (P) cortex (transformed values). Levels were significantly higher in old vervets than middle-aged animals in both regions (all ps < 0.05). (B) Guanidine- (dark bars) and RIPA-extracted (striped bars) PHF tau in temporal (T) and parietal (P) cortex (transformed values). RIPA-extracted PHF-tau was higher in temporal cortex for older animals, whereas no age difference was observed for parietal cortex. Guanidine-extracted levels were significantly higher in parietal than temporal cortex (P < .05) for both age groups. Abbreviations: Aβ, β-amyloid; PHF, paired helical filament. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2019 15, 93-105DOI: (10.1016/j.jalz.2018.06.3057) Copyright © 2018 The Authors Terms and Conditions

Fig. 5 Spearman rank-order correlations between CSF tau-P181 and MRI volume for (A) right prefrontal, (B) left inferior temporal, and (C) right posterior temporal regions. Higher tau-p181 values were associated with reduced volumes. Abbreviations: CSF, cerebrospinal fluid; MRI, magnetic resonance imaging. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2019 15, 93-105DOI: (10.1016/j.jalz.2018.06.3057) Copyright © 2018 The Authors Terms and Conditions

Fig. 6 Spearman rank order correlations between CSF Aβ42 and cerebral metabolic rate of glucose utilization in (A) left hippocampus and (B) right cingulate. Abbreviations: CSF, cerebrospinal fluid; Aβ, β-amyloid. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2019 15, 93-105DOI: (10.1016/j.jalz.2018.06.3057) Copyright © 2018 The Authors Terms and Conditions